Exane Derivatives’s JFrog FROG Stock Holding History

Exane Derivatives’s Portfolio FROG Stock Details FROG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,470	Closed	-$82.7K	–	912
2021 Q3	$82.7K	Buy	2,470 +1,153	+88%	+$46.3K	0.02%	553
2021 Q2	$59.8K	Buy	+1,317	New	+$59.3K	0.01%	626
2021 Q1	–	Sell	-3,692	Closed	-$213K	–	945
2020 Q4	$232K	Buy	+3,692	New	+$257K	0.07%	290

Other funds holding FROG

Sapphire Ventures Austin, Texas $104M AUM 22.23% 1-Year Est. Return

IHG

Insight Holdings Group New York $1.32B AUM 1.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

SGMPI

Spark Growth Management Partners II Boston, Massachusetts $66.6M AUM 51.19% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

OPFM

Optimus Prime Fund Management Grand Cayman, Cayman Islands $1.35B AUM 37.07% 1-Year Est. Return

Exane Derivatives's FROG Position: Q4 2021 in Review

Exane Derivatives sold out of JFrog (FROG) in Q4 2021, closing a stake of 2,470 shares — an estimated $82.7K sold.

Exane Derivatives first reported a position in FROG in Q4 2020 and held it in 3 quarters. The position peaked at $232K in Q4 2020. 179 funds tracked by Wall St. Rank hold FROG as of Q4 2021.

Exane Derivatives reported no remaining JFrog position as of Q4 2021 after selling out during the quarter.
Exane Derivatives sold 2,470 JFrog shares in Q4 2021, an estimated $82.7K.
Exane Derivatives first reported a position in JFrog in Q4 2020 and held it in 3 quarters.
Exane Derivatives's JFrog position peaked at $232K in Q4 2020.
179 funds tracked by Wall St. Rank held JFrog as of Q4 2021.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.